Evalve Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 91

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $410M

Evalve General Information

Description

Developer of devices that repair cardiac valves. The company provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation.

Contact Information

Website
www.evalve.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 4045 Campbell Avenue
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Surgical Devices
Acquirer
Abbott
Corporate Office
  • 4045 Campbell Avenue
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evalve Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 02-Nov-2009 $410M Completed Startup
5. Later Stage VC (Series D) 27-Nov-2007 Completed Generating Revenue
4. Later Stage VC (Series C) 25-May-2004 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Nov-2001 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Sep-1999 $6.5M $6.5M Completed Product Development
1. Seed Round 01-Jan-1999 Completed Startup
To view Evalve’s complete valuation and funding history, request access »

Evalve Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 13,667,233 $0.001000 $0.1 $1.2 $1.2 1x $1.2 15.43%
Series A 5,977,271 $0.001000 $0.09 $1.1 $1.1 1x $1.1 6.75%
To view Evalve’s complete cap table history, request access »

Evalve Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evalve Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABS Ventures Venture Capital Minority
Abbott Ventures Corporate Venture Capital Majority
Apothecary Capital Venture Capital Minority
Cutlass Capital Venture Capital Minority
Delphi Ventures Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Evalve FAQs

  • When was Evalve founded?

    Evalve was founded in 1999.

  • Where is Evalve headquartered?

    Evalve is headquartered in Menlo Park, CA.

  • What is the size of Evalve?

    Evalve has 91 total employees.

  • What industry is Evalve in?

    Evalve’s primary industry is Surgical Devices.

  • Is Evalve a private or public company?

    Evalve is a Private company.

  • What is the current valuation of Evalve?

    The current valuation of Evalve is .

  • What is Evalve’s current revenue?

    The current revenue for Evalve is .

  • How much funding has Evalve raised over time?

    Evalve has raised $118M.

  • Who are Evalve’s investors?

    ABS Ventures, Abbott Ventures, Apothecary Capital, Cutlass Capital, and Delphi Ventures are 5 of 14 investors who have invested in Evalve.

  • When was Evalve acquired?

    Evalve was acquired on 02-Nov-2009.

  • Who acquired Evalve?

    Evalve was acquired by Abbott.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »